Tumor suppressor p53 regulates intestinal type 2 immunity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
07 06 2021
Historique:
received: 02 09 2020
accepted: 30 04 2021
entrez: 8 6 2021
pubmed: 9 6 2021
medline: 29 6 2021
Statut: epublish

Résumé

The role of p53 in tumor suppression has been extensively studied and well-established. However, the role of p53 in parasitic infections and the intestinal type 2 immunity is unclear. Here, we report that p53 is crucial for intestinal type 2 immunity in response to the infection of parasites, such as Tritrichomonas muris and Nippostrongylus brasiliensis. Mechanistically, p53 plays a critical role in the activation of the tuft cell-IL-25-type 2 innate lymphoid cell circuit, partly via transcriptional regulation of Lrmp in tuft cells. Lrmp modulates Ca

Identifiants

pubmed: 34099671
doi: 10.1038/s41467-021-23587-x
pii: 10.1038/s41467-021-23587-x
pmc: PMC8184793
doi:

Substances chimiques

Lrmp protein, mouse 0
Membrane Proteins 0
Tumor Suppressor Protein p53 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3371

Subventions

Organisme : NCI NIH HHS
ID : R01 CA260837
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA227912
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA072720
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA160558
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214746
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA203965
Pays : United States

Références

Nat Immunol. 2015 Feb;16(2):161-9
pubmed: 25531830
Nature. 2016 Jan 14;529(7585):226-30
pubmed: 26762460
Chem Senses. 2010 Feb;35(2):171-7
pubmed: 20071408
Cell Death Dis. 2020 Jul 27;11(7):588
pubmed: 32719388
Nature. 2017 Nov 16;551(7680):333-339
pubmed: 29144463
Nature. 2007 Nov 29;450(7170):721-4
pubmed: 18046411
Viruses. 2010 Jan;2(1):298-313
pubmed: 21994612
Cancer Cell. 2014 Mar 17;25(3):304-17
pubmed: 24651012
Cell Death Dis. 2016 Jul 28;7(7):e2315
pubmed: 27468691
Nature. 2010 Apr 29;464(7293):1367-70
pubmed: 20200518
Cancer Res. 2012 Aug 15;72(16):3948-57
pubmed: 22673234
Nature. 2003 Jul 31;424(6948):516-23
pubmed: 12872134
Annu Rev Immunol. 2019 Apr 26;37:47-72
pubmed: 30379593
J Immunol. 1994 Jul 15;153(2):682-90
pubmed: 8021504
Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2323-7
pubmed: 14983008
Nat Rev Cancer. 2009 Oct;9(10):749-58
pubmed: 19776744
J Exp Med. 2006 Apr 17;203(4):1105-16
pubmed: 16606668
Trends Cell Biol. 2018 Jun;28(6):436-453
pubmed: 29477613
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Nat Rev Immunol. 2015 May;15(5):271-82
pubmed: 25882242
Cell. 1979 May;17(1):43-52
pubmed: 222475
Nat Rev Immunol. 2019 Sep;19(9):584-593
pubmed: 31114038
Development. 2015 Jun 15;142(12):2147-62
pubmed: 26015543
J Immunol. 2019 Mar 1;202(5):1321-1329
pubmed: 30782851
Parasitol Res. 2017 Aug;116(8):2159-2166
pubmed: 28560572
Nature. 1979 Mar 15;278(5701):261-3
pubmed: 218111
J Infect Dev Ctries. 2014 Jan 15;8(1):5-16
pubmed: 24423707
Immunity. 2018 Jul 17;49(1):33-41.e7
pubmed: 30021144
Science. 2016 Mar 18;351(6279):1329-33
pubmed: 26847546
Oncotarget. 2016 Sep 20;7(38):61630-61642
pubmed: 27533082
J Mol Cell Biol. 2019 Apr 1;11(4):284-292
pubmed: 30500901
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
Int J Mol Sci. 2020 Jan 15;21(2):
pubmed: 31952115
Nature. 2011 Jun 15;474(7351):337-42
pubmed: 21677750
PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3106
pubmed: 25144704
BMC Biol. 2013 May 21;11:61
pubmed: 23692866
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
Genome Biol. 2006;7(3):R25
pubmed: 16584535
Curr Protoc Immunol. 2003 Aug;Chapter 19:Unit 19.12
pubmed: 18432905
Cytokine. 2015 Sep;75(1):38-50
pubmed: 26187331
J Mol Cell Biol. 2019 Jul 19;11(7):605-609
pubmed: 31283823
Immunity. 2019 Oct 15;51(4):750-765.e10
pubmed: 31492649
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8467-72
pubmed: 12077306
Nature. 2016 Jan 14;529(7585):221-5
pubmed: 26675736
Cell. 2018 Jul 12;174(2):271-284.e14
pubmed: 29887373
Cytokine. 2015 Sep;75(1):25-37
pubmed: 26073683
Cell. 2013 Apr 11;153(2):449-60
pubmed: 23562644
Nat Rev Immunol. 2016 Dec;16(12):741-750
pubmed: 27667712
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16259-64
pubmed: 21930938
Nat Rev Cancer. 2020 Aug;20(8):471-480
pubmed: 32404993
Cell Rep. 2013 Mar 28;3(3):630-7
pubmed: 23478020
Genes Dev. 1991 Dec;5(12B):2375-85
pubmed: 1752433
Genes Dev. 2017 Aug 15;31(16):1641-1654
pubmed: 28947497
Bio Protoc. 2017 Nov 5;7(21):
pubmed: 29170752
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5564-5569
pubmed: 30819885

Auteurs

Chun-Yuan Chang (CY)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Jianming Wang (J)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Yuhan Zhao (Y)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Juan Liu (J)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Xue Yang (X)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Xuetian Yue (X)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Huaying Wang (H)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Fan Zhou (F)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.

Juan M Inclan-Rico (JM)

Department of Medicine, Rutgers New Jersey Medical School, Rutgers University, Newark, NJ, USA.

John J Ponessa (JJ)

Department of Medicine, Rutgers New Jersey Medical School, Rutgers University, Newark, NJ, USA.

Ping Xie (P)

Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA.

Lanjing Zhang (L)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA.
Department of Pathology, Penn Medicine Princeton Medical Center, Plainsboro, NJ, USA.

Mark C Siracusa (MC)

Department of Medicine, Rutgers New Jersey Medical School, Rutgers University, Newark, NJ, USA.

Zhaohui Feng (Z)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA. fengzh@cinj.rutgers.edu.

Wenwei Hu (W)

Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, NJ, USA. wh221@cinj.rutgers.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH